Category: TCTMD Articles

FDA: Clarithromycin Risks Persist in Patients With CAD

February 26, 2018

“The US Food and Drug Administration (FDA) is alerting clinicians to the possibility of greater risks of cardiovascular morbidity and mortality in patients with heart disease who are prescribed clarithromycin, an issue that first popped up on the radar more than a decade ago.”

Visit Website